Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins.

Ilaria LenciLaura TariciottiTommaso Maria ManziaMartina MilanaAlessandro SignorelloTommaso Maria ManziaLuca TotiGiuseppe TisoneMario AngelicoLeonardo Baiocchi

Published in: Clinical transplantation (2023)

HBIg withdrawal after LT is a safe and efficacious strategy in patients transplanted for HDV/HBV disease and is frequently associated with the spontaneous development of serological immunity against HBV. These data call for a revision of current prophylactic recommendations in this setting.

Keyphrases

hepatitis b virus
liver failure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
total knee arthroplasty
peritoneal dialysis
hiv infected
type diabetes
electronic health record
clinical practice
hiv infected patients
drug induced